Raffa Wealth Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Raffa Wealth Management's EDIT Position: Q3 2026 in Review
Raffa Wealth Management held its Editas Medicine (EDIT) position steady in Q3 2026 at 19 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #1530.
Raffa Wealth Management first reported a position in EDIT in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.36K in Q4 2020. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Raffa Wealth Management held 19 shares of Editas Medicine worth $49 as of Q3 2026.
- Raffa Wealth Management left its Editas Medicine share count unchanged in Q3 2026.
- Editas Medicine made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1530 holding.
- Raffa Wealth Management first reported a position in Editas Medicine in Q4 2020 and has held it in 24 quarters since.
- Raffa Wealth Management's Editas Medicine position peaked at $3.36K in Q4 2020.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.